Call For More Information (410) Skype715-2111
Blog: Recent Posts
  1. ACOG Opinion on Noninvasive Prenatal Genetic Testing

    Noninvasive Prenatal Testing for Fetal Aneuploidy ABSTRACT: Noninvasive prenatal testing that uses cell free fetal DNA from the plasma of pregnant women offers tremendous potential as a screening tool for fetal aneuploidy. Cell free fetal DNA testing should be an informed patient choice after pretest counseling and should not be...
  2. Choosing to Participate in Prenatal Screening for Down Syndrome

    New prenatal screening test for Down syndrome raises questions LEISA SCOTT IT RAINED the day they got the news. Big, pelting drops, as if some screenwriter well-versed in melodrama was dictating the scene. Annie Love couldn’t take the call. She’d been going “slowly nuts” waiting for diagnosis day to arrive...

Is It safe?


Ravgen was designed to be a safe option for mothers. The innovative procedure has been approved by governing bodies. The College of American pathologists (CAP) has recognized and approved the technology. Ravgen technology has received a certificate of accreditation under the Clinical Laboratory Improvement Amendments (CLIA). The prenatal DNA paternity test only requires a safe blood draw from the mother to exclude or confirm a father with over 99% accuracy. We perform reliable DNA testing from fetal DNA present in the mother’s blood after the 8th week of pregnancy. The process and technology has been reviewed, critiqued and approved by governing bodies that verify the safety of Ravgen testing.